Core Insights - Addus HomeCare reported strong Q2 2025 financial results, with revenue and earnings exceeding Wall Street estimates, driven by organic growth and acquisitions [1][2] Financial Performance - Q2 2025 GAAP revenue was $349.4 million, surpassing the estimate of $346.5 million, and reflecting a 21.8% increase from Q2 2024 [2] - Non-GAAP earnings per share reached $1.49, exceeding the consensus of $1.47 and marking a 10.4% year-over-year growth [2] - Adjusted EBITDA was $43.9 million, up 24.4% from $35.3 million in Q2 2024 [2] - Net income increased to $22.1 million, a 22.1% rise from $18.1 million in the previous year [2] - Cash flow from operations was $22.5 million, a 19.7% increase from $18.8 million in Q2 2024 [2] Business Overview - Addus HomeCare operates in 23 states, focusing on personal care, hospice care, and home health services [3] - Personal care services account for 77% of total revenue, with a year-over-year growth of 26.5% [5] - Hospice services contributed 17.8% of revenue, showing a 10.0% organic growth rate [6] - Home health services represented 5.2% of overall revenue, with a slight decline year-over-year [7] Strategic Initiatives - The company aims for organic growth through increased service volumes and rates, alongside strategic acquisitions [4] - Recent acquisitions, including Gentiva Personal Care Services, have enhanced market coverage and service density [5][8] - Technology adoption is progressing, with a caregiver scheduling app being rolled out to improve operational efficiency [8] Market Outlook - The company anticipates robust demand for home-based care and continues to focus on operational efficiency and accretive acquisitions [9] - Organic revenue growth in Personal Care exceeded the long-term target range of 3-5% [9] - Management is closely monitoring government reimbursement rates and regulatory developments, as most revenue is derived from Medicaid and Medicare [10]
Addus HomeCare (ADUS) Q2 Revenue Up 22%